Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia

Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metab...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer Vol. 9; no. 1; p. 284
Main Authors Beesley, Alex H, Rampellini, Janelle L, Palmer, Misty-Lee, Heng, Jasmin Y S, Samuels, Amy L, Firth, Martin J, Ford, Jette, Kees, Ursula R
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 28.10.2010
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations.
AbstractList Abstract Background: Rearrangement of the mixed-lineage leukemia gene (MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL . In this study we have further explored the relationship between MLL status and GC sensitivity. Results: Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL -rearrangements suggested that this relationship represented expression of wild-type MLL . Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL -rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions: The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL -translocations.
Abstract Background Rearrangement of the mixed-lineage leukemia gene ( MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL . In this study we have further explored the relationship between MLL status and GC sensitivity. Results Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL -rearrangements suggested that this relationship represented expression of wild-type MLL . Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL -rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL -translocations.
Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Results Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations.
Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations.
BACKGROUNDRearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. RESULTSNegative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. CONCLUSIONSThe data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations.
Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations.
ArticleNumber 284
Audience Academic
Author Heng, Jasmin Y S
Samuels, Amy L
Ford, Jette
Kees, Ursula R
Palmer, Misty-Lee
Firth, Martin J
Rampellini, Janelle L
Beesley, Alex H
AuthorAffiliation 2 Division of Biostatistics and Genetic Epidemiology, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia
3 Curtin University of Technology School of Pharmacy, Perth, Western Australia
1 Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia
AuthorAffiliation_xml – name: 1 Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia
– name: 2 Division of Biostatistics and Genetic Epidemiology, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia
– name: 3 Curtin University of Technology School of Pharmacy, Perth, Western Australia
Author_xml – sequence: 1
  givenname: Alex H
  surname: Beesley
  fullname: Beesley, Alex H
  organization: Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia
– sequence: 2
  givenname: Janelle L
  surname: Rampellini
  fullname: Rampellini, Janelle L
– sequence: 3
  givenname: Misty-Lee
  surname: Palmer
  fullname: Palmer, Misty-Lee
– sequence: 4
  givenname: Jasmin Y S
  surname: Heng
  fullname: Heng, Jasmin Y S
– sequence: 5
  givenname: Amy L
  surname: Samuels
  fullname: Samuels, Amy L
– sequence: 6
  givenname: Martin J
  surname: Firth
  fullname: Firth, Martin J
– sequence: 7
  givenname: Jette
  surname: Ford
  fullname: Ford, Jette
– sequence: 8
  givenname: Ursula R
  surname: Kees
  fullname: Kees, Ursula R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20979663$$D View this record in MEDLINE/PubMed
BookMark eNqFkktv1DAUhSNURB-wZocsWLBK61cce4M0lNdIA2xgbTnO9dQlsYc4KZoF_x2HKaMOKkJe2Lo-_nR9zj0tjkIMUBRPCT4nRIoLwmtR8krJUpVU8gfFyb5ydOd8XJymdI0xqWXNHxXHFKtaCcFOip_L4LoJggUUHfrhu7YctxtAH1crFANad5ONNg6jt9G3KEFIfvQ3ftwiE1o0QNrEkACNEb35tChb05s1IB_QBlpvxsFbZOw0Auq2_eYqNp1JGYU6mL5B783j4qEzXYInt_tZ8fXd2y-XH8rV5_fLy8WqbARnY2nASCeFwExSIi1mlrWU8ZYQ1ZgKc6IA14Qb54RllagqgpWRkvDWEVc7yc6K5Y7bRnOtN4PvzbDV0Xj9uxCHtTbzHzvQxoJTTQOKVIwLLCSmtHKOOsMElabOrFc71mZqemgthHEw3QH08Cb4K72ON5oqWSvJMuD1DtD4-A_A4Y2NvZ6j1HOUWukcdIa8vO1iiN8nSKPufbLQdSZAnJKWgquqUkr-X4klF4RwmpXP_1Jex2kIORitsgtcZVuz6MVOtDbZLR9czD3aGakXlFMueVXNJp3fo8qrzbHbPMPO5_rBg4vdAzvElAZwez8I1vOo3-PAs7s57PV_Zpv9Anre-yI
CitedBy_id crossref_primary_10_1038_bcj_2014_52
crossref_primary_10_1111_cas_14892
crossref_primary_10_1097_MPH_0000000000002697
crossref_primary_10_1158_0008_5472_CAN_12_3852
crossref_primary_10_18632_oncotarget_11233
crossref_primary_10_1111_bjh_13120
Cites_doi 10.1182/blood-2005-07-3011
10.1111/j.1365-2141.2005.05785.x
10.1016/j.semcancer.2005.01.007
10.1182/blood-2005-11-4728
10.1096/fj.00-0327com
10.1002/gcc.20338
10.1038/sj.bjc.6603447
10.1182/blood-2005-07-2853
10.1016/j.ejca.2005.02.026
10.1182/blood-2003-01-0338
10.1182/blood.V86.10.3861.bloodjournal86103861
10.1074/jbc.M412237200
10.1182/blood-2005-01-0204
10.1038/sj.leu.2404150
10.1073/pnas.0506580102
10.1056/NEJMoa033513
10.1016/j.leukres.2008.08.007
10.1111/j.1365-2141.2005.05433.x
10.1038/emboj.2009.258
10.1182/blood.V86.5.1881.bloodjournal8651881
10.1200/JCO.1998.16.4.1270
10.1038/sj.leu.2402491
10.1182/blood.V94.1.283.413k23_283_290
10.1038/sj.leu.2401129
10.1186/1471-2407-9-147
10.1038/ng1651
10.1111/j.1365-2141.2005.05909.x
10.1182/blood-2008-12-191619
10.1038/sj.leu.2404031
10.1038/nrc2253
10.1111/j.1365-2141.2007.06527.x
10.1038/nature09350
10.1038/sj.leu.2403253
10.1186/1471-2164-6-59
10.1038/sj.bjc.6605072
10.1080/10428190701606826
10.1126/science.1160809
10.1158/0008-5472.CAN-05-3826
10.1111/j.1365-2141.2007.06966.x
10.1038/sj.leu.2402883
10.1073/pnas.1132115100
10.1038/sj.onc.1203145
10.1101/gad.1574507
10.1007/s12185-007-0009-8
ContentType Journal Article
Copyright COPYRIGHT 2010 BioMed Central Ltd.
2010 Beesley et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2010 Beesley et al; licensee BioMed Central Ltd. 2010 Beesley et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2010 BioMed Central Ltd.
– notice: 2010 Beesley et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2010 Beesley et al; licensee BioMed Central Ltd. 2010 Beesley et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7TM
5PM
DOA
DOI 10.1186/1476-4598-9-284
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Nucleic Acids Abstracts
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList Publicly Available Content Database
CrossRef

Nucleic Acids Abstracts



MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-4598
EndPage 284
ExternalDocumentID oai_doaj_org_article_acef9bbe9153460680225ff2fa3628a7
oai_biomedcentral_com_1476_4598_9_284
2503541361
A242484557
10_1186_1476_4598_9_284
20979663
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Australia
GeographicLocations_xml – name: Australia
GroupedDBID ---
-A0
0R~
123
29M
2VQ
2WC
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
H13
HH5
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
PZZ
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
7X8
7TM
5PM
ID FETCH-LOGICAL-b643t-aea8f866038218c03c3d234d119ba50419e0714aff6c35655109a8814df1f7f83
IEDL.DBID RPM
ISSN 1476-4598
IngestDate Tue Oct 22 15:04:34 EDT 2024
Tue Sep 17 21:16:41 EDT 2024
Wed May 22 07:10:31 EDT 2024
Sat Oct 26 00:17:14 EDT 2024
Fri Oct 25 03:59:07 EDT 2024
Thu Oct 10 15:51:18 EDT 2024
Thu Feb 22 23:51:12 EST 2024
Fri Feb 02 04:32:49 EST 2024
Thu Sep 12 20:00:15 EDT 2024
Sat Sep 28 07:59:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b643t-aea8f866038218c03c3d234d119ba50419e0714aff6c35655109a8814df1f7f83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987983/
PMID 20979663
PQID 902249109
PQPubID 42702
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_acef9bbe9153460680225ff2fa3628a7
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2987983
biomedcentral_primary_oai_biomedcentral_com_1476_4598_9_284
proquest_miscellaneous_864955998
proquest_miscellaneous_808461142
proquest_journals_902249109
gale_infotracmisc_A242484557
gale_infotracacademiconefile_A242484557
crossref_primary_10_1186_1476_4598_9_284
pubmed_primary_20979663
PublicationCentury 2000
PublicationDate 2010-10-28
PublicationDateYYYYMMDD 2010-10-28
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-28
  day: 28
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Molecular cancer
PublicationTitleAlternate Mol Cancer
PublicationYear 2010
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 15813846 - Br J Haematol. 2005 Apr;129(2):189-98
7579354 - Blood. 1995 Nov 15;86(10):3861-8
11259387 - FASEB J. 2001 Mar;15(3):693-9
18218047 - Br J Haematol. 2008 Mar;140(6):716-9
10602495 - Oncogene. 1999 Dec 2;18(51):7387-8
20818375 - Nature. 2010 Sep 16;467(7313):343-6
18789525 - Leuk Res. 2009 Feb;33(2):321-5
19436302 - Br J Cancer. 2009 Jun 16;100(12):1926-36
9552025 - J Clin Oncol. 1998 Apr;16(4):1270-8
17117183 - Br J Cancer. 2006 Dec 4;95(11):1537-44
17917979 - Leuk Lymphoma. 2007 Oct;48(10):2083-6
9737681 - Leukemia. 1998 Sep;12(9):1344-8
16293608 - Blood. 2006 Mar 1;107(5):2061-9
16688745 - Genes Chromosomes Cancer. 2006 Aug;45(8):754-60
10381524 - Blood. 1999 Jul 1;94(1):283-90
16651409 - Cancer Res. 2006 May 1;66(9):4591-601
11986959 - Leukemia. 2002 May;16(5):949-51
14712291 - Leukemia. 2004 Mar;18(3):521-9
16200064 - Nat Genet. 2005 Nov;37(11):1289-95
16307022 - Leukemia. 2006 Jan;20(1):179-82
17908926 - Genes Dev. 2007 Oct 1;21(19):2385-98
15869873 - Eur J Cancer. 2005 Jun;41(9):1300-3
15295046 - N Engl J Med. 2004 Aug 5;351(6):533-42
16511515 - Leukemia. 2006 May;20(5):777-84
12782787 - Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7853-8
16445826 - Br J Haematol. 2006 Mar;132(5):539-51
19421859 - Apoptosis. 2009 Jun;14(6):821-8
12941810 - Cancer Res. 2003 Aug 15;63(16):4882-7
12682627 - Leukemia. 2003 Apr;17(4):700-6
19460998 - Science. 2009 May 22;324(5930):1029-33
7655016 - Blood. 1995 Sep 1;86(5):1881-6
17391490 - Br J Haematol. 2007 Apr;137(2):109-16
12730115 - Blood. 2003 Oct 15;102(8):2951-9
15826832 - Semin Cancer Biol. 2005 Jun;15(3):175-88
19763085 - EMBO J. 2009 Oct 21;28(20):3185-95
17957188 - Nat Rev Cancer. 2007 Nov;7(11):823-33
15774615 - Blood. 2005 Jul 1;106(1):345-52
15851483 - J Biol Chem. 2005 Jul 1;280(26):24315-21
16281934 - Br J Haematol. 2005 Nov;131(4):447-56
19749093 - Blood. 2009 Nov 5;114(19):4169-78
15854232 - BMC Genomics. 2005;6:59
16478880 - Blood. 2006 Jun 15;107(12):4663-5
16556894 - Blood. 2006 Jul 15;108(2):441-51
18224408 - Int J Hematol. 2008 Jan;87(1):10-8
19445675 - BMC Cancer. 2009;9:147
16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
SP Whitman (798_CR41) 2005; 106
RA Dickins (798_CR20) 2005; 37
PB Dallas (798_CR19) 2005; 6
MG Vander Heiden (798_CR30) 2009; 324
AH Beesley (798_CR11) 2009; 100
E Klumper (798_CR26) 1995; 86
AH Beesley (798_CR14) 2005; 131
S Takeuchi (798_CR40) 1999; 18
SC Raimondi (798_CR39) 1995; 86
S Schmidt (798_CR35) 2006; 107
C Meyer (798_CR5) 2006; 20
A Kotani (798_CR37) 2009; 114
J Palle (798_CR7) 2005; 129
A Holleman (798_CR17) 2004; 351
RW Stam (798_CR2) 2006; 132
NL Ramakers-van Woerden (798_CR8) 2004; 18
JM Hilden (798_CR3) 2006; 108
M Tonko (798_CR28) 2001; 15
R Pieters (798_CR1) 1998; 12
AV Krivtsov (798_CR24) 2007; 7
AH Beesley (798_CR12) 2006; 95
M Eguchi (798_CR45) 2006; 45
A Daser (798_CR4) 2005; 15
H Liu (798_CR46) 2010; 467
D Wiederschain (798_CR44) 2005; 280
RW Stam (798_CR32) 2006; 20
J Nagayama (798_CR27) 2006; 107
MJ Henderson (798_CR6) 2008; 140
AH Beesley (798_CR13) 2007; 137
CH Pui (798_CR9) 2003; 17
C Ploner (798_CR10) 2009
GJ Kaspers (798_CR25) 2005; 41
NA Heerema (798_CR22) 1998; 16
NL Ramakers-van Woerden (798_CR33) 2002; 16
M Kubicka (798_CR43) 2007; 48
ME Ross (798_CR18) 2003; 102
JC Webb (798_CR38) 1999; 94
N Cerveira (798_CR42) 2009; 9
S Tsutsumi (798_CR16) 2003; 63
H Liu (798_CR29) 2007; 21
ER Lawlor (798_CR34) 2006; 66
Y Dou (798_CR23) 2008; 87
A Subramanian (798_CR15) 2005; 102
S Tyagi (798_CR31) 2009; 28
AH Beesley (798_CR21) 2009; 33
T Rozovskaia (798_CR36) 2003; 100
References_xml – volume: 108
  start-page: 441
  year: 2006
  ident: 798_CR3
  publication-title: Blood
  doi: 10.1182/blood-2005-07-3011
  contributor:
    fullname: JM Hilden
– volume: 131
  start-page: 447
  year: 2005
  ident: 798_CR14
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05785.x
  contributor:
    fullname: AH Beesley
– volume: 15
  start-page: 175
  year: 2005
  ident: 798_CR4
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2005.01.007
  contributor:
    fullname: A Daser
– volume: 107
  start-page: 4663
  year: 2006
  ident: 798_CR27
  publication-title: Blood
  doi: 10.1182/blood-2005-11-4728
  contributor:
    fullname: J Nagayama
– volume: 15
  start-page: 693
  year: 2001
  ident: 798_CR28
  publication-title: FASEB J
  doi: 10.1096/fj.00-0327com
  contributor:
    fullname: M Tonko
– volume: 45
  start-page: 754
  year: 2006
  ident: 798_CR45
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.20338
  contributor:
    fullname: M Eguchi
– volume: 95
  start-page: 1537
  year: 2006
  ident: 798_CR12
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6603447
  contributor:
    fullname: AH Beesley
– volume: 107
  start-page: 2061
  year: 2006
  ident: 798_CR35
  publication-title: Blood
  doi: 10.1182/blood-2005-07-2853
  contributor:
    fullname: S Schmidt
– volume: 41
  start-page: 1300
  year: 2005
  ident: 798_CR25
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2005.02.026
  contributor:
    fullname: GJ Kaspers
– volume: 102
  start-page: 2951
  year: 2003
  ident: 798_CR18
  publication-title: Blood
  doi: 10.1182/blood-2003-01-0338
  contributor:
    fullname: ME Ross
– volume: 86
  start-page: 3861
  year: 1995
  ident: 798_CR26
  publication-title: Blood
  doi: 10.1182/blood.V86.10.3861.bloodjournal86103861
  contributor:
    fullname: E Klumper
– volume: 280
  start-page: 24315
  year: 2005
  ident: 798_CR44
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M412237200
  contributor:
    fullname: D Wiederschain
– volume: 106
  start-page: 345
  year: 2005
  ident: 798_CR41
  publication-title: Blood
  doi: 10.1182/blood-2005-01-0204
  contributor:
    fullname: SP Whitman
– volume: 20
  start-page: 777
  year: 2006
  ident: 798_CR5
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404150
  contributor:
    fullname: C Meyer
– volume: 102
  start-page: 15545
  year: 2005
  ident: 798_CR15
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0506580102
  contributor:
    fullname: A Subramanian
– volume: 351
  start-page: 533
  year: 2004
  ident: 798_CR17
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa033513
  contributor:
    fullname: A Holleman
– volume: 33
  start-page: 321
  year: 2009
  ident: 798_CR21
  publication-title: Leuk Res
  doi: 10.1016/j.leukres.2008.08.007
  contributor:
    fullname: AH Beesley
– volume: 129
  start-page: 189
  year: 2005
  ident: 798_CR7
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05433.x
  contributor:
    fullname: J Palle
– volume: 28
  start-page: 3185
  year: 2009
  ident: 798_CR31
  publication-title: EMBO J
  doi: 10.1038/emboj.2009.258
  contributor:
    fullname: S Tyagi
– volume: 86
  start-page: 1881
  year: 1995
  ident: 798_CR39
  publication-title: Blood
  doi: 10.1182/blood.V86.5.1881.bloodjournal8651881
  contributor:
    fullname: SC Raimondi
– volume: 16
  start-page: 1270
  year: 1998
  ident: 798_CR22
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1998.16.4.1270
  contributor:
    fullname: NA Heerema
– volume: 16
  start-page: 949
  year: 2002
  ident: 798_CR33
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2402491
  contributor:
    fullname: NL Ramakers-van Woerden
– volume: 94
  start-page: 283
  year: 1999
  ident: 798_CR38
  publication-title: Blood
  doi: 10.1182/blood.V94.1.283.413k23_283_290
  contributor:
    fullname: JC Webb
– volume: 63
  start-page: 4882
  year: 2003
  ident: 798_CR16
  publication-title: Cancer Res
  contributor:
    fullname: S Tsutsumi
– volume: 12
  start-page: 1344
  year: 1998
  ident: 798_CR1
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2401129
  contributor:
    fullname: R Pieters
– volume: 9
  start-page: 147
  year: 2009
  ident: 798_CR42
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-9-147
  contributor:
    fullname: N Cerveira
– volume: 37
  start-page: 1289
  year: 2005
  ident: 798_CR20
  publication-title: Nat Genet
  doi: 10.1038/ng1651
  contributor:
    fullname: RA Dickins
– volume: 132
  start-page: 539
  year: 2006
  ident: 798_CR2
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2005.05909.x
  contributor:
    fullname: RW Stam
– volume: 114
  start-page: 4169
  year: 2009
  ident: 798_CR37
  publication-title: Blood
  doi: 10.1182/blood-2008-12-191619
  contributor:
    fullname: A Kotani
– volume: 20
  start-page: 179
  year: 2006
  ident: 798_CR32
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404031
  contributor:
    fullname: RW Stam
– volume: 7
  start-page: 823
  year: 2007
  ident: 798_CR24
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2253
  contributor:
    fullname: AV Krivtsov
– volume: 137
  start-page: 109
  year: 2007
  ident: 798_CR13
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2007.06527.x
  contributor:
    fullname: AH Beesley
– volume: 467
  start-page: 343
  year: 2010
  ident: 798_CR46
  publication-title: Nature
  doi: 10.1038/nature09350
  contributor:
    fullname: H Liu
– volume: 18
  start-page: 521
  year: 2004
  ident: 798_CR8
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2403253
  contributor:
    fullname: NL Ramakers-van Woerden
– volume: 6
  start-page: 59
  year: 2005
  ident: 798_CR19
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-6-59
  contributor:
    fullname: PB Dallas
– volume: 100
  start-page: 1926
  year: 2009
  ident: 798_CR11
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6605072
  contributor:
    fullname: AH Beesley
– volume-title: Apoptosis
  year: 2009
  ident: 798_CR10
  contributor:
    fullname: C Ploner
– volume: 48
  start-page: 2083
  year: 2007
  ident: 798_CR43
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428190701606826
  contributor:
    fullname: M Kubicka
– volume: 324
  start-page: 1029
  year: 2009
  ident: 798_CR30
  publication-title: Science
  doi: 10.1126/science.1160809
  contributor:
    fullname: MG Vander Heiden
– volume: 66
  start-page: 4591
  year: 2006
  ident: 798_CR34
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-3826
  contributor:
    fullname: ER Lawlor
– volume: 140
  start-page: 716
  year: 2008
  ident: 798_CR6
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2007.06966.x
  contributor:
    fullname: MJ Henderson
– volume: 17
  start-page: 700
  year: 2003
  ident: 798_CR9
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2402883
  contributor:
    fullname: CH Pui
– volume: 100
  start-page: 7853
  year: 2003
  ident: 798_CR36
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1132115100
  contributor:
    fullname: T Rozovskaia
– volume: 18
  start-page: 7387
  year: 1999
  ident: 798_CR40
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203145
  contributor:
    fullname: S Takeuchi
– volume: 21
  start-page: 2385
  year: 2007
  ident: 798_CR29
  publication-title: Genes Dev
  doi: 10.1101/gad.1574507
  contributor:
    fullname: H Liu
– volume: 87
  start-page: 10
  year: 2008
  ident: 798_CR23
  publication-title: Int J Hematol
  doi: 10.1007/s12185-007-0009-8
  contributor:
    fullname: Y Dou
SSID ssj0017874
Score 2.0231152
Snippet Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and...
Abstract Background Rearrangement of the mixed-lineage leukemia gene ( MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated...
Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor...
Abstract Background: Rearrangement of the mixed-lineage leukemia gene (MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated...
BACKGROUNDRearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor...
BACKGROUND: Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor...
Abstract Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 284
SubjectTerms Acute lymphocytic leukemia
Apoptosis
Cancer
Cancer therapies
Cell cycle
Cell Line, Tumor
Colleges & universities
Corticosteroids
Deoxyribonucleic acid
DNA
DNA damage
DNA Damage - genetics
Drug resistance
Drug Resistance, Neoplasm - genetics
Drug therapy
Experiments
Gene expression
Genes
Genetic aspects
Glucocorticoids - pharmacology
Health aspects
Humans
Lymphocytes - drug effects
Medical research
Myeloid-Lymphoid Leukemia Protein - genetics
Myeloid-Lymphoid Leukemia Protein - metabolism
Oligonucleotide Array Sequence Analysis
Pediatrics
Physiological aspects
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism
Proteins
Reverse Transcriptase Polymerase Chain Reaction
Risk factors
RNA Interference
SummonAdditionalLinks – databaseName: BiomedCentral
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMQFQXmFFuQDElwsYsdxbHHaAlVB3Z6oVHGxbMdWV2yTqps99ND_3nEeS90iLkh7iifWJvP6Jp4HQu-t9NRWpSHOFJ5wKUpivaCEhTp4CN6CsrHeeX4kDo75j5Py5E-z6Fsn-FSKT5RXgvBSgV4SsKX30QMWO6rEwHzv1-bAAOSuP0CeiMcuPn_Z4FZl-zJxSH3f_rvW-YZ7SlMnb_ii_afoyQgi8Wzg-jN0zzfb6OEwVvJyGz2ajwfmz9HV92kICW4DBlxck_jRFc8PD3Hb4D5hHeJP2Kdd1HgVs9mHcRLYNDW-GBJoPe5a_PVoRmpzBuYHLxp8Pk34wMatO4-XlyAVrQUoDlvhpV__9mcL8wId73_7-eWAjBMXiAVk0hHjjQxSiLyQ4PpdXriiZgWvKVXWlDmnyseCJxOCcAVAQVBoZaSkvA40VEEWL9FW0zb-NcKOygBSWrLcMF5Sp6wzAB4Yr60C1CUz9Dlhgz4fumvo2O86XQHV05GJOjJRKw1MzNDHiWmbG_twRoq7pHuRqcn-_QUQMj2qpzbOg1Rar8ABcBHnkYCdC4EFAw5emipDH6JI6Kj18J-cGYsX4Flj_yw9i1U2kpclUO4mlKCtLlnemYRKj9ZipVUEUoDbVIbwZjXeGBPgGt-uV1rmABRj3fM_SASP7QQVvNpXg5BunpnlqoK4tshQlYhv8lLSlWZx2jcbZ0pWShZv_otdO-hxn3UBPyZ30VZ3sfZvAcx19l2vxtf1ZEeB
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXRMtraUE-IMHFapw4zlg9LY-qoG5PVOrNsh1brNgmVTd76IH_zjiP1ZpKcEHaUzyx1p7P9jfxPAh5Z8FzW5WGOVN4JkCWzHrJWR7q4NF4C8rGeOfFhTy7FN-uyqudUl_RJ2xIDzxM3LFxHuWtV7g0hYyVIhCBIeTB4NYLZogjz9RkTI33BwjD_j5ZVJKJUsGY1IeDPN4-Y4rl8Geg-yo5n_o0_vc3653TKvWk3DmaTp-SJyOnpPNhLPvkgW8OyMOhyuTdAXm0GO_Pn5FfX6eaJLQNFGlyzeI3WLo4P6dtQ3v_dTRHsZ92WdN1dG4fqktQ09T0dvCn9bRr6eeLOavNNe5GdNnQm6ngBzVu03m6ukOQtBaZOXZFV37z018vzXNyefrl-6czNhZgYBaJSseMNxBAyqwAZAIuK1xR54WoOVfWlJngysf4JxOCdAUyQ1zfygBwUQceqgDFC7LXtI1_RajjEBC0ZZ6ZXJTcKesMcolc1FYhCYMZOUnUoG-GZBs6pr9OW3Al6qhEHZWolUYlzsiHSWnbF3vrBuR90Y9RqUn__QMEnR5Bp_8Fuhl5HyGh4yaA_8mZMZYBxxrTael5DLoBUZYoeZRI4uJ1SfPhBCo9bh5rrSKvQhqnZoRuW-OL0R-u8e1mrSFD3hjDoP8iIkXMLqhwal8OIN2OOc9UhWZuMSNVAt9kUtKWZvmjzz2eK6gUFK__xywekse9Lwb-cjgie93txr9BitfZt_1q_g3K9k8n
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLegE2gXBOOrbCAfkOBiLXYcxxYH1MGmgdYKISbtZtmOPSq6pOvHYQf-d54Tt1qYNKmn2rGSvN977-f4fSD03kpPbVkY4kzuCZeiINYLSliogofNW1A25juPJ-L0nH-_KC5SbM4yhVVubGJrqKvGxW_khyo6G_Bt6vP8msSmUfFwNXXQeIh2GGwUsgHaOTqe_Pi5PUYANPJUz4dKcUh5KQgvFKg4YfL_HPdZzzW1Ffzv2ulbjqofRHnLK508RU8SncSjTv7P0ANf76FHXYPJmz30eJyOzp-jv9827UhwEzAw5IrEz694fHaGmxq3oeuwE4V1mmmFlzGuvWssgU1d4UUXSuvxqsFfJyNSmSswRHha4_mm1wc2br3yeHYD-GgskHJYCs_8-o-_mpoX6Pzk-NeXU5J6LxALHGVFjDcySCGyXAIJcFnu8orlvKJUWVNknCofU59MCMLlQApBtZWRkvIq0FAGmb9Eg7qp_WuEHZUB8FqwzDBeUKesM0AjGK-sAv4lh-hTTwx63tXZ0LHydX8EAKGjEHUUolYahDhEHzdC217YbmykuDv1KAq1t377R7O41ElRtXEe8Gm9AlfARexMAhYvBBYMuHppyiH6ECGho_7DPTmT0hjgWWMlLT2K-TaSFwXMPOjNBL11veH9Dah0shtLvUX5EOHtaLwwhsLVvlkvtcyAMsYM6HumCB4LCyp4ta86kG6fmWWqhB1uPkRlD769l9Ifqae_27LjTMlSyfzNvfe9j3bb-Ar4MXmABqvF2r8F2ray75Jy_gP24EWN
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQFQXmFFuQDElwMseM4thBCy6MqqNsTK_Vm2Y4NK7ZJ2c1K7IH_zjiPbUOrSjmtHSv2fGN_s54HQi-t9NQWuSHOZJ5wKXJivaCEhTJ4MN6CsjHeeXosDmf820l-cl4OqF_A1ZWmXawnNVsu3vz5vfkACv--VXgp3lJeCMJzBZpLYLe9iW4xDmZ69OPj51cKgMz2inno3Of5uWKA_2LfF6Mjq83sf3n_vnCAjZ0rL5xWB_fRvZ5m4kmHiwfohq920e2u8ORmF92Z9lfqD9Hfr0OZElwHDMy5JPFvWTw9OsJ1hVuXdrBQYZx6XuJV9HfvCk5gU5V42bnYetzU-PPxhJTmFDYoPK_w2VADBBu3bjxebAA3tQWyDkPhhV__8qdz8wjNDr58_3RI-poMxAJ3aYjxRgYpRJpJIAcuzVxWsoyXlCpr8pRT5WNIlAlBuAzIIqi8MlJSXgYaiiCzx2inqiv_FGFHZQAc5yw1jOfUKesM0AvGS6uAl8kEvRuJQZ91-Td0zIg9bgHl1FGIOgpRKw1CTNDrQWjbF1uDR4rLXT9GoY7Gb3-olz90r8DaOA-4tV7BEcFFrFgCO2EILBigANIUCXoVIaEjUuGbnOnDG2CuMcOWnsQ4HMnzHHruj3qCPrtR894AKj2og1aRagGzUwnC29b4YnSRq3y9XmmZApWMkdHXdBE8JhxUsLRPOpBu58xSVYDlmyWoGMF3tCjjlmr-s01HzpQslMyeXT-tPXS3dbyAh8l9tNMs1_458LnGvmj19B_W60is
  priority: 102
  providerName: Scholars Portal
Title Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
URI https://www.ncbi.nlm.nih.gov/pubmed/20979663
https://www.proquest.com/docview/902249109
https://search.proquest.com/docview/808461142
https://search.proquest.com/docview/864955998
http://dx.doi.org/10.1186/1476-4598-9-284
https://pubmed.ncbi.nlm.nih.gov/PMC2987983
https://doaj.org/article/acef9bbe9153460680225ff2fa3628a7
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2IRAXBANG2ah8QIKL1zhxEluc2rFpVGs1DSZVXCzbsSGiTap-HHbgf-c5H9XCJA5IVSrFH0ryfs_v5-R9IPRec0t1GitiVGQJ40lMtE0oCV3mLGzenNA-3nkyTS5v2XgWz_ZQ3MbCVE77RuenxXxxWuQ_K9_K5cIMWj-xwfXkLISNsuDRYB_tA0DbLXrz6QAQyJocPpQnA8rShLBYgFoTWIp98t9ApEDyo79C3Ocdy1Ql8H-4TN-zU10fyntG6eI5etawSTysr_oF2rPFIXpc15e8O0RPJs2X85fo95e2GgkuHQaCnBH_9hVPrq5wWeDKcx02ojBPmWd47d3a67oSWBUZXtWetBZvSvx5OiSZWsA6hPMCL9tSH1iZ7cbi-R3Ao9TAyWEqPLfbX3aRq1fo9uL829klaUovEA0UZUOUVdzxJAkiDhzABJGJsjBiGaVCqzhgVFgf-aScS0wEnBA0WyjOKcscdanj0Wt0UJSFfYOwodwBXOMwUCGLqRHaKGARIcu0APrFe-hTRwxyWafZkD7xdbcFdFB6eUovTykkyLOHPrZC2w2s9jU8edh15IXamb86Ua5-yAZeUhkL8NRWgCVgiS9MAguec6FTYOm5Snvog4eE9OoP12RUE8UA9-oTacmhD7fhLI6h50mnJ6it6TQft6CSzbKxlsIzKiBwoofwrtUP9J5whS23a8kDYIw-APofXRLm8woKeLRHNUh399xiv4fSDnw7D6XbAkpYZR1vlO7tf488Rk8r1wv4hfwEHWxWW_sOGN1G90GPZ2kfPRoOx1_H8D86n17f9Kv3I3CcMA7Hm9H3fqXpfwAiyFSl
link.rule.ids 108,230,315,730,783,787,867,888,2109,2228,12068,21400,24330,24949,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,76146,76147
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagiMcFQXktLeADElysxonj2OKAlke1hd09tVJvlu3YZcU2WfZx6IH_zkySXTVUqpRT7FhJ5puZz8k8CHnvVOCuyC3zNgtMKJkzFyRnaSxjgM1b1A7znSdTOToTP87z8y42Z9WFVW5tYmOoy9rjN_Ijjc4GfJv-vPjDsGkU_lztOmjcJfewDBc2MCjOd_stDlgUXTUfruQRF4VkIteg4CxV_2e4z3uOqanff9NKX3NT_RDKaz7p-Al53JFJOmyl_5TcCdU-ud-2l7zaJw8m3Y_zZ-TvybYZCa0jBX5cMvz4SifjMa0r2gSuwz4U1qlnJV1hVHvbVoLaqqTLNpA20HVNv02HrLSXYIborKKLbacPav1mHej8CtBRO6DksBSdh83vcDmzz8nZ8ffTryPWdV5gDhjKmtlgVVRSJpkCCuCTzGdlmomSc-1sngiuAyY-2Rilz4ASgmJrqxQXZeSxiCp7QfaqugqvCPVcRUBrniY2FTn32nkLJCIVpdPAvtSAfOqJwSzaKhsG6173RwAOBoVoUIhGGxDigHzcCm13YbOtUfLm1C8o1N76zYl6eWE6NTXWB0CnCxocgZDYlwTsXYxptODolS0G5ANCwqD2wz152yUxwLNiHS0zxGwbJfIcZh72ZoLW-t7wwRZUprMaK7PD-IDQ3SheiIFwVag3K6MSIIyY_3zLFCmwrKCGV_uyBenumdNEF7C_zQak6MG391L6I9XsV1N0PNWq0Cp7fet9vyMPR6eTsRmfTH8ekEdNpAUcqToke-vlJrwBArd2bxs1_QcHyEcY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgiIkLH-OrbIAPSHBJGyeOY4tT2ag2aKsdmDRxsWzHhmptUrXpYUj87zzno2o2icOknOpnK05-7_n3mveB0AfNLdFpogKjYhtQzpJAW0aCyGXOgvPmhPb5zpMpO72g3y6Ty51WX1XQvtGzfj5f9PPZ7yq2crkwgzZObHA-OY7AURY8HiwzN7iPHoDOhqx11JsPCIBD2lTyIZwNCE1ZQBMByh2AQfYlgEORAtWPbyS6zzvnU1XG_7ax3jmtupGUO0fT6An62W6qjki56m9K3Td_btR7vNOun6LHDWHFw1rkGbpn8wP0sG5heX2A9ifNx_nn6O9Z2_AEFw4DB88C_wcvnozHuMhxFRwPvi6sU8wyvPaR83XrCqzyDK_qYF2LywKfTIdBphZg6vAsx8u2mwhWZlNaPL8GBBYaaD8shed2c2UXM_UCXYy-_jg-DZruDoEGFlQGyiruOGNhzIFmmDA2cRbFNCNEaJWElAjrk6uUc8zEQDvBeAjFOaGZIy51PH6J9vIit68RNoQ70IgkClVEE2KENgqISkQzLYDh8R763HnHcllX8pC-tnZ3BNRcerBIDxYpJIClhz61iNhOrFwnzm6LfvGI6axf_VCsfsnmXUplLGiAtgIOG8p87xOwqc5FTgGZ4CrtoY8eb9JbGLgno5pECdirr9Ulhz6jh9MkAcmjjiRYBtMZPmwRKxvLtJbCkzbgiKKH8HbUT_TBdrktNmvJQyClPsf6PyKM-tKFAh7tq1oDtntuFauH0o5udB5KdwQQXxU2bxD-5s4z36P985ORHJ9Nvx-iR1WgB1wRP0J75Wpj3wJ_LPW7ylL8A5pocj4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+wild-type+MLL+on+glucocorticoid+sensitivity+and+response+to+DNA-damage+in+pediatric+acute+lymphoblastic+leukemia&rft.jtitle=Molecular+cancer&rft.au=Beesley%2C+Alex+H&rft.au=Rampellini%2C+Janelle+L&rft.au=Palmer%2C+Misty-Lee&rft.au=Heng%2C+Jasmin+YS&rft.date=2010-10-28&rft.pub=BioMed+Central+Ltd&rft.issn=1476-4598&rft.eissn=1476-4598&rft.volume=9&rft.spage=284&rft_id=info:doi/10.1186%2F1476-4598-9-284&rft.externalDocID=A242484557
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon